ABVC BioPharma, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
ABVC BioPharma, Inc. (ABVC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $11.80 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-08-12
- ABVC BioPharma, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2026-06-30 was $5.20K, a 23.11% decline year-over-year.
- ABVC BioPharma, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2026-03-31 was $6.60K, a 38.25% decline year-over-year.
- ABVC BioPharma, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2025-06-30 was $6.76K.
- ABVC BioPharma, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for the quarter ending 2025-03-31 was $10.68K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 6 month |
|---|---|---|
| 2026-06-30 | $5.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $11.80K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $6.60K 10-Q · filed 2026-05-18 | |
| 2025-06-30 | $6.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $17.45K 10-Q · filed 2026-08-12 |
| 2025-03-31 | $10.68K 10-Q · filed 2026-05-18 |